Cheryl Platzman Weinstock is an award–winning journalist who reports about health and science research and its impact on society. Her investigative pieces have brought attention to mental health, medical ethics issues and the medical research gender gap. She also writes for the Metro desk of The New York Times.
Cheryl Platzman Weinstock
From this contributor
The deep emotional ties between depression and autism
Autistic people are four times as likely to experience depression over the course of their lives as their neurotypical peers. Yet researchers know little about why, or how best to help.
The deep emotional ties between depression and autism
The hidden danger of suicide in autism
Many people with autism entertain thoughts of suicide and yet show few obvious signs of their distress. Some scientists are identifying risks — and solutions — unique to autistic individuals.
The hidden danger of suicide in autism
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.